What is Covectra?
Founded in 2008 and headquartered in Westborough, Massachusetts, Covectra is at the forefront of developing serialization-based solutions designed to combat drug abuse, diversion, and counterfeiting. The company's offerings include robust track and trace capabilities. Covectra has also established its presence in the cloud with the launch of its AuthentiTrack serialization database, a platform engineered for serial number generation, management, and aggregation, providing a comprehensive approach to product lifecycle management and supply chain integrity.
How much funding has Covectra raised?
Covectra has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Covectra?
The recent major strategic investment signals a pivotal moment for Covectra, likely enabling accelerated expansion of its serialization and track and trace technologies. Given the large-scale late-stage funding context, this capital infusion is expected to fuel further product development, enhance market penetration, and potentially support strategic partnerships or acquisitions. Covectra is well-positioned to capitalize on the increasing global demand for supply chain security and pharmaceutical traceability solutions.
See full Covectra company page
